RxDoctor Payments Data

Stamatios Lerakis, MD

Cardiovascular Disease · New York, NYNPI 1043227895

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (49.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Medtronic at 56.1% of the total. Reporting peaked in 2023 at $8,780 and has fallen 85.2% since, to $1,301 in 2025. Among cardiovascular disease clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$26,339in general payments, 2019–2025

Across 139 payments — averaging $189.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$15K
  • Abbott$7K
  • Edwards Lifesciences$3K
  • Heartflow, Inc.$692
  • Philips North America LLC$259
  • Shockwave Medical, Inc$201
  • plus $395 from 6 others

What the payments were for

  • Speaking & faculty fees$13,00049%
  • Travel & lodging$5,73022%
  • Food & beverage$7,35028%
  • Gifts$2591%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$26,339 in reported general payments places this provider in the 90th percentile of 2,302 cardiovascular disease providers in New York.

See all cardiovascular disease providers in New York →

Medicare billing

Part B allowed, 2024
$275,134
Medicare patients
2,504
Services billed
5,668

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →